CLOs on the Move

DGH Technology

www.dghkoi.com

 
DGH Technology is a Exton, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Physio-Control

Physio-Control, now part of Stryker, is the world leader in the development, manufacture, sale and service of external defibrillator/monitors and emergency medical response products and services. We envision a world in which no person dies suddenly as a result of an acute, treatable medical event. Physio-Control Team Members are part of a unique group who love what they do - and why they do it. Our Team is comprised of talented individuals who have purpose, creativity and passion, and we are proud to be leading the industry dedicated to saving and extending lives around the globe. Our Team Members are our most valuable asset and what sets us apart from our competitors. We are committed to our mission to save lives through hard work and dedication.

Omni International, LLC

Omni International, LLC is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Shamrock Marketing De

Shamrock Marketing De is a Chino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Exo

Exo (pronounced “Echo”) is pioneering a high-performance handheld ultrasound platform and AI for imaging and therapeutic applications.

Palette Life Sciences

Palette Life Sciences is a fully integrated medical device company providing a wide range of products and services that improve quality of life of patients. Our portfolio of products focuses on treating conditions in urology/urogynecology disorders, colorectal conditions, radiotherapy, and interventional oncology procedures. For physicians, researchers, and inventors alike, progress begins with a natural curiosity and the drive to do more. By discovering and applying new applications of proven medicine to uncommon, or difficult to treat conditions, we can address the needs of patients often overlooked by traditional medical companies. Inspired by innovation and empathy, we see endless possibilities in expanding on proven technologies to elevate patient care. The foundation for all of our breakthrough products is Non-Animal Stabilized Hyaluronic Acid (NASHA®). NASHA has been proven safe and effective for more than two decades in over 50 million medical procedures worldwide. Barrigel® - the first and only FDA-cleared hyaluronic acid rectal spacer, minimizing the side effects of radiation therapy for prostate cancer patients. Barrigel is available in the US, Australia and Europe. Deflux® - the only FDA-approved injectable treatment for vesicoureteral reflux (VUR), a urinary defect that affects 1% of children worldwide. Deflux for VUR is available in the US, Canada, Europe, Japan, Latin America, Australia and New Zealand. Also indicated for stress urinary incontinence (SUI) in women, Deflux for SUI is available in Canada and Europe.